https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-13 / Gen Thorac Cardiovasc Surg 2009 Sep;57(9):449-57
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-13 / Gen Thorac Cardiovasc Surg 2009 Sep;57(9):449-572009-09-13 00:00:002019-02-15 08:34:56Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-92008-12-13 00:00:002008-12-13 00:00:00Mechanisms of murine dendritic cell antitumor dysfunction in aging
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-04 / Lung Cancer 2009 Jul;65(1):1-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-04 / Lung Cancer 2009 Jul;65(1):1-82008-12-04 00:00:002019-02-15 08:34:57Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-11 / Lung Cancer 2009 Feb;63(2):247-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-11 / Lung Cancer 2009 Feb;63(2):247-502008-07-11 00:00:002019-02-15 08:34:58Inoperable Pancoast tumors treated with hyperthermia-inclusive multimodality therapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-06 / Cancer Gene Ther. 2008 Dec;15(12):795-807
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-06 / Cancer Gene Ther. 2008 Dec;15(12):795-8072008-06-06 00:00:002008-06-06 00:00:00Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-01 / Cancer Biother. Radiopharm. 2008 Jun;23(3):321-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-01 / Cancer Biother. Radiopharm. 2008 Jun;23(3):321-312008-06-01 00:00:002019-02-15 08:35:00Antitumor effect of lung cancer vaccine with umbilical blood dendritic cells in reconstituted SCID mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-01 / Int. J. Oncol. 2008 Jun;32(6):1317-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-01 / Int. J. Oncol. 2008 Jun;32(6):1317-242008-06-01 00:00:002019-02-15 08:35:00IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-29 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Jan;73(1):128-35
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-29 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Jan;73(1):128-352008-05-29 00:00:002019-02-15 08:34:59Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-04-01 / Int. J. Oncol. 2008 Apr;32(4):851-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-04-01 / Int. J. Oncol. 2008 Apr;32(4):851-602008-04-01 00:00:002019-02-15 08:35:01Hyperthermia switches glucose depletion-induced necrosis to apoptosis in A549 lung adenocarcinoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Methods Mol. Biol. 2008;423:139-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Methods Mol. Biol. 2008;423:139-532008-01-01 00:00:002019-02-15 08:48:15Delivery of whole tumor lysate into dendritic cells for cancer vaccination
